-
Mashup Score: 3Inovio Announces Results from its Phase 2 COVID-19 Vaccine Trial - 3 year(s) ago
Investigators report the vaccine demonstrated it was safe, well-tolerated, and immunogenic in all age groups.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 2
Inovio sued its longstanding contract manufacturer, alleging the company won’t transfer crucial data to other companies that could produce its vaccine.
Source: STATCategories: Future of Medicine, Latest HeadlinesTweet
Investigators report the #inovio #COVID19 #vaccine demonstrated it was safe, well-tolerated, and immunogenic in all age groups. @InovioPharma https://t.co/Lbhn9EE2O4